Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01902719 · ClinicalTrials.gov registry record · NA

Achieving Blood Pressure Control Together Study

A NA study of Hypertension, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
159
Enrollment target
1
Study location

NCT01902719: Completed NA study of Hypertension, sponsored by Johns Hopkins University.

NCT01902719 is a NA study of Hypertension that has completed, run by Johns Hopkins University. The registered enrollment target is 159 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01902719, a NA study of Hypertension, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
159 participants
Enrollment target
1
Study location

Study Summary

African Americans represent a particularly vulnerable subgroup of persons with hypertension, as they are more likely than Whites to have hypertension, equally as likely to be aware of it and to be treated for it, but less likely to achieve blood pressure control while receiving treatment. African Americans are also more likely than Whites to suffer end organ damage as a result of hypertension. Patients' hypertension self-management behaviors (including adherence to prescribed care, self-blood pressure monitoring, lifestyle changes, and shared medical decision-making) represent a cornerstone of hypertension therapy. Evidence suggests some African Americans with hypertension may experience difficulties carrying out positive self-management behaviors, in part due to cultural beliefs and practices, knowledge and perceptions regarding the nature and consequences hypertension, and lack of systems to support ongoing engagement in prescribed care within their communities. Substantial evidence has demonstrated the important role of family and community support in improving patients' management of a variety of chronic illnesses. The goal of this study is to rigorously test the effectiveness of hypertension self-management interventions that engage African American patients, their families, and their community-level resources to improve African American patients' blood pressure. We hypothesize patients' hypertension control rates may be improved when combining community health worker self-management support with other types of hypertension self-management skills training.

Primary Outcome

Hypertension control based on JNC-7 guidelines and changes in systolic and diastolic blood pressure. Blood pressure (BP) will be measured by trained and certified observers during regularly scheduled clinical visits at EBMC using an automatic oscillometric monitor (Omron HEM 907-XL). This device programs a five-minute delay before activation and has a 30-second delay between the triplicate measurements. We will use two measures - the average of all three measurements and the average of the last

Conditions Studied

Interventions

  • BEHAVIORAL Community Health Worker (CHW) Intervention
  • BEHAVIORAL Communication Skills Training
  • BEHAVIORAL Problem Solving Skills Training

Study Locations (1)

Maryland

  • Johns Hopkins East Baltimore Medical Center - Baltimore

Trial Details

FieldValue
Enrollment Target 159 participants
Start Date 2013-09
Est. Completion 2015-08
Phase NA
Johns Hopkins University

1,448 total trials

What the finished NCT01902719 record still lists

NCT01902719 is an interventional study that assigns participants to a tested intervention. The registered 159 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 3 interventions - of which Community Health Worker (CHW) Intervention is the first listed.

NCT01902719 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT01902719 about?

NCT01902719 is a clinical study titled "Achieving Blood Pressure Control Together Study". African Americans represent a particularly vulnerable subgroup of persons with hypertension, as they are more likely than Whites to have hypertension, equally as likely to be aware of it and to be treated for it, but less likely to achieve blood pressure control while receiving treatment. African Am...

What is the current status of trial NCT01902719?

This trial is currently completed. It is a NA study. The enrollment target is 159 participants. The study started on 2013-09. Estimated completion is 2015-08.

What conditions does trial NCT01902719 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT01902719?

The interventions under investigation include: Community Health Worker (CHW) Intervention (BEHAVIORAL), Communication Skills Training (BEHAVIORAL), Problem Solving Skills Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT01902719?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01902719 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01902719's enrollment target sits among peer trials

159 244th of 470 higher than 227 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05267626 · 159 participants · Phase 1

    Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

  • NCT06321575 · 159 participants · NA

    The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)

  • NCT06729151 · 159 participants

    Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain Syndrome

  • NCT07023731 · 159 participants · Phase 1

    A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01902719, the US trial registry maintained by the National Library of Medicine. NCT01902719 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.